Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank57
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-22.41M
↑ 28% vs avg
Percentile
P57
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-31.09M
Historical baseline
PeriodValueYoY Change
TTM$-22.41M+62.6%
2024$-59.92M+26.2%
2023$-81.18M-972.9%
2022$-7.57M+79.7%
2021$-37.33M-38.2%
2020$-27.01M+28.0%
2019$-37.52M-64.4%
2018$-22.83M-28.5%
2017$-17.77M-777.5%
2016$2.62M-